EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY 4.0

Model‐Derived Iopamidol Clearance and Creatinine‐Based Kidney Function Estimates After Trauma: A Retrospective Cohort Study

Manjunath P Pai iD, Aleksas Matvekas iD, Lu Wang, Levi T Hooper iD, June Sullivan iD, Raymond Jean iD, Kathleen A Stringer iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-12 · 46 (12)

DOI: 10.1002/phar.70219 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 09.11.2026. Verfasst von Manjunath P Pai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Creatinine, Iopamidol, Contrast Media, Wounds and Injuries. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study Objective To determine whether iopamidol administered during clinically indicated contrast‐enhanced computed tomography (CE‐CT) and measured in remnant serum can provide an individualized surrogate value for measured glomerular filtration rate (mGFR) after trauma to compare against creatinine‐based estimates.

Design

Single‐center retrospective observational cohort.

Setting

Academic medical center. Patients Seventy‐six adults evaluated for trauma who underwent iopamidol‐enhanced CT and had at least one quantifiable postcontrast concentration and serum creatinine measurement.

Intervention

None. Measurements and Main Results Population parameters of a previously developed two‐compartment structural model were re‐estimated using the study data and stochastic approximation expectation–maximization, followed by participant‐specific conditional‐mode clearance estimation. Individual iopamidol clearance was interpreted as mGFR (mGFR IOP ). Agreement with Cockcroft–Gault creatinine clearance and nonindexed Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) creatinine estimated GFR was assessed; 449 serum creatinine measurements were modeled over 7 days. Median mGFR IOP was 99 mL/min (interquartile range, 59–125). Each 30‐mL/min higher mGFR IOP was associated with a 0.11‐mg/dL lower serum creatinine at iopamidol administration (95% confidence interval, 0.06–0.16; p < 0.001). Predicted serum creatinine values converged over 7 days despite differences in mGFR IOP (interaction p < 0.001). Estimates were within 30% of mGFR IOP in 71% of patients for CKD‐EPI versus 59% for Cockcroft–Gault ( p = 0.035). CKD‐EPI had narrower 95% limits of agreement compared with Cockcroft‐Gault (−73 to 57 vs. −82 to 74 mL/min, respectively) but increasingly underestimated higher mGFR IOP (proportional‐bias p < 0.001).

Conclusion

Cohort‐specific iopamidol clearance estimates as a surrogate for mGFR can be generated from routine CE‐CT and remnant serum samples that differ from creatinine‐based estimates. Prospective validation against conventional mGFR is required before clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CreatinineIopamidolContrast MediaWounds and InjuriesModels, BiologicalKidneyHumansRetrospective StudiesFemaleGlomerular Filtration RateMaleMiddle AgedAdultKidney Function TestsCohort StudiesTomography, X-Ray ComputedAged

Stichwörter der Autor:innen

contrast mediacreatininedrug dosage calculationsglomerular filtration ratekidney function testsmultiple trauma

Substanzen

CreatinineIopamidolContrast Media

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Surgery, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Max Harry Weil Institute for Critical Care Research and Innovation, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Manjunath P Pai, Aleksas Matvekas, Levi T Hooper, June Sullivan, Raymond Jean, Kathleen A Stringer

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Pai, M. P., Matvekas, A., Wang, L., Hooper, L. T., Sullivan, J., Jean, R., & Stringer, K. A. (2026). Model‐Derived Iopamidol Clearance and Creatinine‐Based Kidney Function Estimates After Trauma: A Retrospective Cohort Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(12). https://doi.org/10.1002/phar.70219

Vancouver

Pai MP, Matvekas A, Wang L, Hooper LT, Sullivan J, Jean R, et al. Model‐Derived Iopamidol Clearance and Creatinine‐Based Kidney Function Estimates After Trauma: A Retrospective Cohort Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(12). doi:10.1002/phar.70219

BibTeX
@article{Pai2026,
  author = {Pai, Manjunath P and Matvekas, Aleksas and Wang, Lu and Hooper, Levi T and Sullivan, June and Jean, Raymond and Stringer, Kathleen A},
  title = {Model‐Derived Iopamidol Clearance and Creatinine‐Based Kidney Function Estimates After Trauma: A Retrospective Cohort Study},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2026},
  volume = {46},
  number = {12},
  doi = {10.1002/phar.70219}
}
Kostenlos starten →